COMPANIES: INDUSTRIES:
Biotechnology Jobs & Careers Search
Find your next job in Biotechnology. Search Biotechnology jobs from thousands of job and career search sites.
A search engine for jobs with a different approach to job and career searches. In one simple search, job
seekers get free access to millions of employment opportunities from thousands of websites. Find your next job in Biotechnology today.
Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize
Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation. She is being honored with the prestigious ...
GENEART Again Honored with "BAVARIA'S BEST 50" Award
GENEART AG is among the 50 most dynamic companies in Bavaria and has been awarded "BAVARIA'S BEST 50" by the Bavarian State Ministry for the third time. Since its market entry in 2000, GENEART ...
Study shows that a combination of common genetic variations can lead to schizophrenia
A multi-national group of investigators, including a scientist at the University of North Carolina at Chapel Hill, has discovered that nearly a third of the genetic basis of schizophrenia may be ...
Lu AA24530 shows positive results in major depressive disorder phase II study
H. Lundbeck A/S announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD). The primary objective of the ...
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel ...
IOP announces 2009 award winners
Successful business applications such as drug screening technologies, flat-panel displays and solar-cell designs are amongst the achievements in physics recognised by the Institute of Physics' (IOP) ...
Alzheimer's research yields potential drug target
Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may ...
Genetically engineered mice yield clues to 'knocking out' cancer
Deleting two genes in mice responsible for repairing DNA strands damaged by oxidation leads to several types of tumors, providing additional evidence that such stress contributes to the development ...
NIST issues human milk and blood serum SRMs for contaminant measurements
Responding to scientists' need to measure organic contaminants in human body fluids, the National Institute of Standards and Technology (NIST) has recently made four new Standard Reference Materials ...
Comprehensive and User-Friendly Biotech News, Constantly Updated
BionityCOM, an online information portal provided by Chemie.DE Information Service GmbH, now offers the most comprehensive coverage of news for the biotech and pharma industries in Europe. ...
Pharming confirms positive results from final analysis of Rhucin studies
Pharming Group NV announced that, as part of the activities for the regulatory submission files, it has now also completed the final analysis of its Rhucin® randomised placebo-controlled studies. The ...
André Choulika succeeds Philippe Pouletty as Chairman of France Biotech
At the Annual General Meeting, the members of France Biotech voted to elect their governing bodies, in accordance with the organization's statutes. The newly elected Administrative Council then ...
ChemWerth, Inc. announces Wuhan Pharmaceutical Factory passes FDA inspection
ChemWerth Inc. reported the Wuhan Pharmaceutical Factory facility has passed an FDA overseas inspection with a two point 483 being issued. ChemWerth and Wuhan are collaborating to develop APIs for ...
LANXESS disinfectant effective against swine flu viral strain
A recent study carried out on behalf of LANXESS has demonstrated the effectiveness of the disinfectant Preventol CD 601 against the swine flu viral strain. "The test results from Giessen University ...
Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma ...
MorphoSys and the University of Melbourne File New Patent Applications in MOR103 Program
MorphoSys AG and the University of Melbourne announced an agreement to cooperate on investigating new therapeutic applications for MorphoSys's MOR103 program. MOR103, a HuCAL antibody against human ...
Kelvin Lee winner of Biochemical Engineering Journal Young Investigator Award
The Biochemical Engineering Journal and the ECI Biochemical Engineering Conferences have announced that Kelvin H. Lee, Gore Professor of Chemical Engineering at the University of Delaware and ...
Evotec Announces the Successful Completion of the First Phase I Study with EVT 401
Evotec AG announced the successful completion of the first Phase I study with its P2X7 receptor antagonist EVT 401. EVT 401 is a small molecule drug candidate and a potentially novel approach to ...
Researchers of VTT, the University of Turku and the University of Heidelberg discover new information on spreading of cancer
A joint research group of VTT Technical Research Centre of Finland and the University of Turku, led by Professor Johanna Ivaska, has discovered a mechanism lung cancer cells use when spreading into ...
Thermo Fisher Scientific Wins Microsoft Pharmaceutical and Life Sciences Innovation Award in Informatics
Thermo Fisher Scientific Inc. announced that it has been named the winner of the Microsoft Corporation 2009 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation ...
Bionity.COM News
The latest news about trends and developments in the biotech, pharma and life science industries
Johnson & Johnson to Buy $1 Billion Elan Corporation PLC Stake, Work on Alzheimer's
Bloomberg -- Johnson & Johnson agreed to pay $1 billion for a stake in Elan Corp. and will develop the Irish drugmakers medicines against Alzheimers disease.
Over 250 New Jobs at Eisai Company, Ltd.'s New HQ
NeoGenomics Laboratories Expansion to Create 75 New Jobs in Lee County
How Does the Faltering Economy Affect Jobs in Pharmaceutical Services?
What to Discuss During Interviews for Jobs in the Biotechnology Field
Pfizer Inc.'s Sutent Fails in Colon Cancer, Trial Halted
Maxygen, Inc. Plans Staff Cuts After Forming R&D Joint Venture With Astellas Pharma Inc.
CombinatoRx, Incorporated to Merge with Privately Held Neuromed Pharmaceuticals
Maxygen, Inc., Astellas Pharma Inc. Seal Research Pact, CEO will Exit
Roche Drops Out Of PhRMA, Joins Biotechnology Industry Organization (BIO)
Biogen Idec, Inc. (Massachusetts) Gains Rights to Acorda Therapeutics's MS Drug; to Get $110 Million Up Front
Interferon Alpha Can Delay Full Onset Of Type I Diabetes, University of Texas Medical School Study
Creation of New Jobs Planned for
Ketamine Safe for Endrotracheal Intubation, Study
TB Vaccine Could Kill Babies With HIV, World Health Organization Reports
Acid-Reducing Medicines May Lead To Dependency, University of Copenhagen Study
Medidata Solutions, Inc. Prices Initial Public Offering
Radiation Not Needed In Common Childhood Cancer, St. Jude Children's Research Hospital Study
Medtronic, Inc. And Stryker Corporation Bone-Growth Proteins Show Risk in New Study At Brigham and Women's Hospital
UCB Group and Biogen Idec, Inc. (Massachusetts) Discontinue Phase II Clinical Trial of CDP323
Repros Therapeutics Inc. to Stop Using 50 mg Dose in Fibroids Study
Study Dismisses Protein's Role in Heart Disease, Imperial College London Study
Children Can Inhale Growth Hormone, Study
Tumor-Suppressor Recruits Help To Overcome A Barrier And Fix Cancer-causing Defects, University of Texas MD Anderson Cancer Center Study
Novartis Corporation Sees FDA Decision on Menveo Early 2010 US After Regulator Seeks More Data on Meningitis Vaccine
FDA Approves AMAG Pharmaceuticals, Inc.'s Feraheme(TM) to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
Eisai Corporation of North America and Pfizer Inc. Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
NeoStem, Inc. Raises Additional Funds from Principals of and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million
Novel Epigenetic Markers Of Melanoma May Herald New Treatments For Patients, Yale University Study
U.S. FDA Casts Doubt on Lantus Cancer Link
Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company
Spectrum Pharmaceuticals, Inc. to Raise $21 Million from Institutional Investors at $7.1525 Per Share
Charles River Laboratories (Massachusetts) Announces RMS Succession Plan and Organizational Enhancements
Morphotek Inc. Announces a Research Collaboration Agreement with Synageva BioPharma to Develop Potential Treatments for Cancer and Infectious Disease
Europe Approves AstraZeneca PLC Lung Cancer Drug
Georgetown University Medical Center Study May Help Explain "Awakenings" That Occur With Popular Sleep-Aid Ambien
Sanofi-Aventis (France) Remodels R&D, Eight Sites Close, No Forced Layoffs
AMAG Pharmaceuticals, Inc. Expects FDA Action on Anemia Drug Within Days
Roche Holding AG Stops Selling Acne Drug Accutane
Facebook Taps Ex-Genentech, Inc. CFO for Finance Chief
Second Gene Linked To Familial Testicular Cancer, National Institutes of Health (NIH) Study
Wyeth, Catalyst Biosciences, Inc. Sign Deal Worth Potentially $500 Million
Takeda Pharmaceutical Co. Ltd. Fails to Get U.S. Approval for Diabetes Drug
Drug-Resistant Flu Strain Turns Up in Denmark but Doesn???t Last Long
RNA Snippet Suppresses Spread Of Aggressive Breast Cancer, Whitehead Institute Study
Early Heart Attack Therapy With Bone Marrow Extract Improves Cardiac Function, University of California, San Francisco (UCSF) Study
Diabetics Urged To Stay On Popular Sanofi-Aventis K.K.'s Insulin Lantus
BioSante Pharmaceuticals, Inc. to Buy Cell Genesys, Inc. for $38 Million
Teva Pharmaceutical Industries Limited, Optimata Ltd. Partner to Make Cancer Drugs Work
ULURU Inc. Restructured Operations to Conserve Cash to Further the Company's Business
Women With Cystic Fibrosis Can Have Safe And Successful Fertility Treatment, Study
Hyperion Therapeutics Raises $60 Million Series C
Pfizer Inc. Offers EU Remedies Over Planned Wyeth Buy
Collegium Pharmaceutical, Inc. Announces the Sale of AllerNaze(TM) to Lupin Ltd.
GE Healthcare, Geron Corporation to Develop Stem Cell Products
Sanofi-Aventis (France) Drug May Increase Cancer Risk, Studies Find
Novartis Corporation in Talks to Buy Much of Elan Corporation PLC
TapImmune Inc. Announces Corporate Restructuring
BioPharm Executive: Sprinting to the Finish
Jury Returns $1.67 Billion Drug Verdict Against Abbott Laboratories
PPD, Inc. Confirms Takeda Pharmaceutical Co. Ltd. Receives FDA Complete Response for Alogliptin; to Conduct More Trials
PPD is partnering with... Drug Companies Defend Acetaminophen as FDA Considers Restrictions
Biogen Idec, Inc. (Massachusetts) Reports 10th Case of PML Brain Infection in Patient Taking Tysabri
Vical Incorporated's H1N1 Flu Vaccine Shows Promise
Closed Pore Could Trap Malaria, The Burnet Institute and The Walter and Eliza Hall Institute of Medical Research and Deakin University Report
Scientists Kill Cancer Cells With "Trojan Horse", EnGeneIC Pty Ltd Study
Insulin Analogue Glargine Possibly Increases Cancer Risk,
New Techniques Make More Ovary Transplants Possible, May Help Women Fight Biological Clock, And Studies
Synthetic Biology: Gene Therapy Gets Under The Skin, ETH Zurich Study
A Potent And Selective Anti-Tumor Agent On Human Gastric Cancer, China Medical University Study
Advanced Nerve Cell System Could Help Cure Diabetic Neuropathy, Related Diseases, University of Central Florida Study
Statins Can Protect Against Alzheimer???s Disease, According To New Study At University of Groningen
Gyros AB Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
Celera Corporation Grants License to Bayer Schering Pharma for Cancer-Related Targets
Lundbeck Inc. (formerly Ovation Pharmaceuticals) Shares Drop as Drug Hits FDA Snag
Paladin Labs Inc. to Buy Some Products from Wyeth
deCODE genetics, Inc. Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
EU Lifts Restrictions on UCB Group's Neupro
Celesio AG Buys Majority Stake in Brazil's Panpharma
New Drug Promising Against Rheumatoid Arthritis, New Study in Says
Teva Pharmaceutical Industries Limited and Antares Pharma, Inc. Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R)
Adeona Pharmaceuticals Announces Appointment of as Chief Executive Officer and President
University of Texas MD Anderson Cancer Center Researchers Pinpoint A New Enemy For Tumor-Suppressor p53
New Treatment for Rheumatoid Arthritis Looks Promising, Study
Histamine Affects Alcohol-related Behavior, Study
Mylan Inc. Announces Strategic Collaboration with BioCon Limited to Enter the Global Generic Biologics Market
Researchers Identify A Novel Mechanism That Could Be Targeted To Prevent Cancer Spread, National Cancer Institute Study
Asia's Party Drug Ketamine Carries Incontinence Risk
Promising Biomarker And Candidate Tumor Suppressor Gene Identified For Colorectal Cancer, Maastricht University Medical Center Study
Quotient BioResearch Creates 40 Science Jobs at New ??15 Million Plant
Sanofi Pasteur To Fill US Vaccine Supply Gap Caused By Merck & Co., Inc.
Cancer Researchers Link DICER1 Gene Mutation To Rare Childhood Cancer, Children's National Medical Center Study
FDA Stops Shipments of 33 Generic Drugs from Caraco Pharmaceutical Laboratories, Ltd. Plants
Four Post-Exposure Rabies Jabs Sufficient, Announces
Enzyme Fights Mutated Protein In Inherited Parkinson's Disease, UT Southwestern Medical Center Study
BizJournals -- Maxygen Inc. and Japanese drug maker Astellas Pharma Inc. will start an R&D joint venture focused on protein drugs but largely spelling the beginning of the end of the Redwood City company as it is known today.
EurekAlert! -- HOUSTON (July 1, 2009) A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.
NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced the pricing of its initial public offering of 6,300,000 shares of common stock at $14.00 per share. In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to 945,000 shares of common stock at the initial public offering price to cover...
News-Medical -- A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through...
NIH -- Specific variations or mutations in a particular can gene raise a man's risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease, according to new research by scientists at the National Institutes of Health. This is only the second gene to be identified that affects the risk of familial testicular cancer, and the first gene in a key biochemical pathway...
Whitehead Institute -- A low cellular level of a tiny fragment of RNA appears to increase the spread of breast cancer in mouse models of the disease, according to researchers at Whitehead Institute for Biomedical Research.
UCSF -- A UCSF study for the treatment of heart failure after heart attack found that the extract derived from bone marrow cells is as effective as therapy using bone marrow stem cells for improving cardiac function, decreasing the formation of scar tissue and improving cardiac pumping capacity after heart attack.
WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. today announced that Takeda Pharmaceutical Company Limited issued a news release reporting that Takeda Global Research & Development Center, Inc., its wholly-owned U.S. subsidiary, has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for alogliptin.
EurekAlert -- The risk of cancer possibly increases if patients with diabetes use the long-acting insulin analogue glargine instead of human insulin. The Institute for Quality and Efficiency in Health Care (IQWiG), in collaboration with the "Wissenschaftliches Institut der AOK" (WIdO), the research institute of the German Local Health Care Fund, analysed the data of almost 130,000 patients with diabetes...
News-Medical -- Golimumab, a new tumour necrosis factor-a (TNF-a) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-a inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-a inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
EurekAlert -- Researchers at The University of Texas M. D. Anderson Cancer Center have identified a protein that marks the tumor suppressor p53 for destruction, providing a potential new avenue for restoring p53 in cancer cells.
Reuters - Revelers across Asia who snort the animal tranquilizer ketamine for a hallucinogenic high may face incontinence and other health problems as new dangers of this cheap party drug start showing up in long-term studies.